1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Venetoclax with azacitidine for treating acute myeloid leukaemia before and after an allogeneic stem cell transplant ID 6468

Awaiting development [GID-TA11581] Expected publication date: TBC

  • Project information
  • Project documents

28698-Venetoclax-with-Azacitidine-for-Acute-Myeloid-Leukaemia-V1.0-MAY2024-NON-CONF.pdf (nihr.ac.uk)